DrugJul 5, 2023
The Harvard Drug Group Tramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count recall — FDA D-0878-2023
Packaging defect: blister packaging inadequately sealed.
Class IIFDA: TerminatedThe Harvard Drug Group
Recall history in this database
Classification mix: Class II: 2, Class III: 1.
DrugMay 17, 2023
Gabapentin Tablets, USP 600 mg recall — FDA D-0570-2023
Product mixup: one foreign tablet found in product.
Class IIIFDA: TerminatedThe Harvard Drug Group
DrugMar 8, 2023
The Harvard Drug Group Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose recall — FDA D-0432-2023
Packaging defect: observed packaging defect, blister packaging inadequately sealed.
Class IIFDA: TerminatedThe Harvard Drug Group
Understanding this recall history
This page summarizes recall records in which the official source identifies The Harvard Drug Group as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.